Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Sida 1 från 24 resultat
Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This application includes as part of its disclosure a biological sequence listing which is being concurrently submitted through EFS-Web. Said biological sequence listing is contained in a file named "56256o1204.txt" which was created on Dec. 15, 2016, and has a size of 238,677 bytes, and is hereby
Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The sequence listing in the file named "67858o702005.txt" having a size of 238,525 bytes that was created Nov. 25, 2008 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in
Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This application claims priority to U.S. Ser. No. 12/153,612 filed May 21, 2008, U.S. Ser. No. 12/153,611 filed May 21, 2008, U.S. Ser. No. 12/124,723 filed May 21, 2008, provisional patent application No. 60/924,550, filed May 21, 2007, and provisional patent application No. 60/924,551, filed May
Antagonists of IL-6 to treat cachexia, weakness, fatigue, and/or fever
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies and novel therapies and therapeutic protocols using anti-IL-6 antibodies, preferably those
Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies and novel therapies and therapeutic protocols using anti-IL-6 antibodies, preferably those
Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and /or fever
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies and novel therapies and therapeutic protocols using anti-IL-6 antibodies, preferably those
NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
1. Field of the invention
The invention relates to a pharmaceutical and a method for treating Chronic Fatigue Syndrome and alleviating the symptoms thereof. More particularly, the invention relates to the use of reduced forms of nicotinamide-adenine-dinucleotide (NADH) or
Anti-fatigue composition used for increasing endurance performance, and use of the same
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to a composition, which comprises a first component being a Cistanche tubulosa extract and a second component being ubiquinone (Q10) and/or ubiquinol (QH). The present invention also relates to the uses of the composition in anti-fatigue,
Anti-IL-6 antibody for use in the treatment of cachexia
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
SEQUENCE LISTING
The sequence listing in the file named "43257o2014.txt" having a size of 335,872 bytes that was created Mar. 30, 2015 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention
Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The sequence listing in the file named "67858o707005.txt" having a size of 332,004 bytes that was created Nov. 23, 2009 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in
Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of pharmaceutical chemistry and formulation. More particularly, it concerns the use of an effective amount of riboflavin and amino acids, in any combination, in the alleviation of the
Medication and treatment for disease
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to a treatment for diseases, such as fibromyalgia, depression, and auto-immune and immuno-suppressive diseases, including MS.
BACKGROUND OF THE INVENTION
Various diseases can include symptoms such as fatigue, muscle aches, muscle spasms, tingling
Composition for the prevention of muscle fatique and skeletal muscle adaptation of strenuous exercise
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The present invention relates to a composition for the prevention and treatment of muscular energetic deficiencies, states of asthenia and muscle fatigue, states of heart fatigue and post-infarct conditions and for enhancing sporting performances.
Accordingly, the composition may take the form and
Use of tropical root crops in dietary intervention strategies
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
(1) Field of Invention
This invention relates to an effective dietary intervention plan. In one aspect all food is withheld for a period of at least 5 days, except for tropical root crops. In another aspect the invention relates to the treatment of various symptoms,
Method for the management of cancer and cancer treatment-related comorbidities
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The invention concerns a method for the management of cancer and treatment cancer comorbidities, including but not limited to cancer-related fatigue, cachexia, anorexia, pain, anemia, asthenia, depression, impaired cognitive function, loss of appetite, muscle weakness, nausea,
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
